FDA Approves Breakthrough Pancreatic Cancer Drug | Lubbock News

FDA just approved a groundbreaking new pill, Rasonque, for the most common type of pancreatic cancer — a disease that’s long been considered nearly untreatable. Targeting a mutated protein found in 90% of cases, this drug doubled survival rates and slashed serious side effects compared to chemo. What makes it even more remarkable? It arrived six months ahead of schedule, fueled by public buzz after a former senator credited it with easing his pain. Scientists once called these mutated proteins “undruggable,” but this breakthrough could unlock new treatments for other cancers too — including lung cancer — thanks to the revolutionary “molecular glue” technology behind it. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8875f62ff21e09e1